How Manganese Interacts With Weight Loss Medications
Use caution · The honest verdict
Worth a conversation with your clinician
Manganese has no documented pharmacokinetic interaction with semaglutide or tirzepatide; it is an essential trace mineral required for superoxide dismutase (MnSOD) antioxidant function and carbohydrate metabolism enzymes, but supplemental manganese has a narrow safety window — the tolerable upper intake level is only 11 mg/day for adults, neurological toxicity occurs at chronic high intake (manganism), and most people get adequate manganese from diet with no need to supplement.
Manganese is an essential trace mineral, but unlike magnesium or iron, it has no established clinical benefit for people taking GLP-1 medications. The real concern isn't a drug interaction — it's that the gap between the amount you need and the amount that becomes toxic is dangerously small. Most adults already get enough from food, making separate manganese supplements an unnecessary risk with no clear reward.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Why they interact
Here's what actually happens when Manganese meets Antacids and proton pump inhibitors may reduce manganese absorption; iron, calcium, and magnesium compete for divalent metal transporter-1 (DMT1) absorption — high supplemental doses of these reduce manganese absorption and vice versa; no documented pharmacokinetic interaction with GLP-1 drugs; no CYP450, serotonin, or blood glucose mechanism linking manganese to semaglutide or tirzepatide — in plain language.
Manganese (Mn) is a transition metal essential in trace amounts — the adequate intake (AI) is 1.8 mg/day for adult women and 2.3 mg/day for adult men. It functions as a cofactor for arginase (urea cycle), pyruvate carboxylase (gluconeogenesis), glutamine synthetase (nitrogen metabolism), and most critically, manganese superoxide dismutase (MnSOD) — the primary mitochondrial antioxidant enzyme. MnSOD is of interest in the context of metabolic disease because mitochondrial oxidative stress is elevated in obesity and may contribute to insulin resistance. The tolerable upper intake level (UL) is 11 mg/day for adults. Chronic high intake — primarily from occupational dust inhalation (welders) but also documented with high oral supplement doses — causes manganism, a Parkinson's-like neurological syndrome featuring tremors, rigidity, and psychiatric symptoms, because manganese preferentially accumulates in the basal ganglia. Absorption: manganese is absorbed through divalent metal transporter-1 (DMT1) in the small intestine, which is shared with iron, calcium, and magnesium; high co-supplementation of these minerals reduces manganese absorption. GLP-1 drugs slow gastric emptying, which may affect the kinetics of mineral absorption from the GI tract, though this effect on manganese specifically is unstudied. Most dietary manganese comes from nuts, whole grains, legumes, and tea — deficiency in adults on varied diets is extremely rare.
What the research says
NIH ODS manganese fact sheet establishes the AI, UL, deficiency, toxicity, and food sources. The ATSDR toxicological profile for manganese documents the manganism mechanism and occupational exposure risks. No direct manganese and semaglutide or tirzepatide co-administration studies exist. The MnSOD and metabolic disease connection is supported by emerging mechanistic literature but is not an established clinical recommendation.
Does it depend on which GLP-1?
The picture can differ slightly across medications. Here's what to know for each.
Semaglutide (Ozempic, Wegovy)
No documented pharmacokinetic interaction with semaglutide; semaglutide is cleared by peptide cleavage, not CYP450; manganese does not affect GLP-1 receptor signaling or semaglutide levels; the safety concern is manganese's own narrow therapeutic window (dietary adequacy vs. neurotoxicity), independent of GLP-1 mechanism.
Tirzepatide (Mounjaro, Zepbound)
Same rationale as semaglutide; no pharmacokinetic interaction; same narrow-window toxicity concern.
When and how to take it
No specific timing restriction relative to GLP-1 drug administration; if supplementing, take manganese-containing products separately from large iron, calcium, or magnesium doses to optimize absorption; do not exceed 11 mg/day from supplements; dietary manganese from food does not require restriction; disclose all mineral supplements to prescriber; most people do not need a separate manganese supplement if consuming nuts, whole grains, and legumes.
Signs to watch for
- Tremors, muscle rigidity, or gait changes (early manganism — warrants immediate discontinuation and medical evaluation if neurological symptoms appear during supplementation)
- Psychiatric symptoms — mood changes, anxiety, compulsive behaviors — documented in manganese toxicity
- Fatigue, weakness (non-specific but worth monitoring alongside mineral panels)
- No specific GLP-1 interaction warning signs beyond the above
What to do about it
Practical, non-prescriptive steps — the specifics still belong to you and your clinician.
Stop any separate manganese supplement immediately if neurological symptoms appear and contact your prescriber.
Check all supplement labels for hidden manganese — many 'trace mineral complexes' and multivitamins contain it.
Prioritize dietary manganese from food sources rather than supplements.
If you have liver disease, avoid supplemental manganese entirely due to impaired biliary excretion.
What Manganese Actually Does — Essential Trace Mineral With a Narrow Window
Manganese is a trace mineral your body needs in tiny amounts — but the distance between 'enough' and 'too much' is alarmingly short. It serves as a cofactor for several enzymes, meaning it helps those enzymes do their jobs, but it does not need to be supplemented in most people.
The adequate intake (AI) for manganese is just 1.8 mg per day for adult women and 2.3 mg for adult men. Most adults on a typical varied diet consume between 1.5 and 5 mg daily from food alone, easily meeting this requirement. Black tea, hazelnuts, whole wheat bread, tofu, mussels, and pineapple are all rich sources.
Manganese's biochemical roles are real and important: it activates arginase in the urea cycle, pyruvate carboxylase in gluconeogenesis, and glutamine synthetase in nitrogen metabolism. Its most famous role is as a component of manganese superoxide dismutase (MnSOD), the primary antioxidant enzyme inside your mitochondria. This is the function most often cited in supplement marketing.
The paradox is that manganese is simultaneously essential — deficiency impairs bone development and enzyme function — and neurotoxic at elevated intake. This is why it rarely appears in standalone supplement discussions despite being present in most multivitamins. The risk-reward calculation simply doesn't favor supplementation for the vast majority of people.
- Adequate Intake (AI): 1.8 mg/day (women), 2.3 mg/day (men)
- Typical dietary intake: 1.5–5 mg/day from food
- Top food sources: black tea, mussels, hazelnuts, whole wheat bread, tofu, pineapple
- Primary biochemical roles: MnSOD (mitochondrial antioxidant), pyruvate carboxylase (gluconeogenesis), arginase (urea cycle)
Bottom line
Manganese sufficiency is met by diet for almost all adults — there is no established clinical benefit to supplementing separately, and the narrow gap between the adequate intake and the upper limit makes unnecessary supplementation a risk without reward.
Manganism — Neurotoxicity at the Upper Limit
Manganism is not a theoretical risk. It is a well-documented neurological toxicity syndrome with clinical features that closely resemble Parkinson's disease: tremors, bradykinesia (slowed movement), rigidity, and a mask-like facial expression. The distinction shows up on MRI, where manganese deposits preferentially in the basal ganglia rather than the substantia nigra.
The tolerable upper intake level (UL) for manganese is 11 mg per day for adults. This number is critical because some 'comprehensive mineral' or 'trace mineral complex' products provide 5 to 10 mg of manganese per serving — perilously close to the toxicity threshold. Taking two such products, or combining a high-potency mineral supplement with a manganese-rich multivitamin, can push daily intake past the UL.
Chronic dietary exposure from high rice or grain intake does not typically cause toxicity because manganese from food has limited bioavailability compared to supplemental forms. The real danger comes from concentrated supplement doses. Patients with liver disease are at particularly high risk because manganese is excreted primarily through bile, and impaired liver function reduces the body's ability to clear it.
The occupational exposure story — welders inhaling manganese dust and developing manganism — is well known in toxicology. What is less discussed is that oral supplement doses can achieve the same neurological outcome over time. This is not a rare idiosyncratic reaction; it is a predictable consequence of exceeding the body's capacity to regulate manganese.
- Tolerable Upper Intake Level (UL): 11 mg/day for adults
- Manganism symptoms: tremors, rigidity, bradykinesia, mask-like facies, psychiatric changes
- Highest risk: patients with liver disease (impaired biliary manganese excretion)
- Food manganese is safer than supplemental forms due to lower bioavailability
Bottom line
Manganism is a real neurological toxicity syndrome with clinical features resembling Parkinson's disease; it does not require extreme doses — chronic supplementation at or above the 11 mg/day UL, particularly in patients with liver disease, can cause it; this is why separate manganese supplementation without a documented deficiency is hard to justify.
MnSOD and Metabolic Health — the Antioxidant Argument for Manganese
The most common marketing claim for manganese supplements is that they support antioxidant function through MnSOD and therefore help with blood sugar control. The biochemistry is real, but the clinical leap is not supported by evidence.
MnSOD (manganese superoxide dismutase, also called SOD2) is the primary antioxidant enzyme inside mitochondria. It converts superoxide radicals — the inevitable byproducts of the electron transport chain — into hydrogen peroxide, which is then neutralized by other enzymes. In obesity, mitochondrial oxidative stress is elevated, and this oxidative burden contributes to adipose tissue inflammation and insulin resistance. The logic follows: if manganese is required for MnSOD, more manganese might mean more antioxidant protection.
The problem is that in the absence of manganese deficiency, MnSOD activity is not limited by manganese availability. The enzyme is constitutively expressed, meaning your body makes as much of it as it needs, and the manganese cofactor is incorporated during synthesis. Dumping more manganese into the system does not upregulate MnSOD activity. The rate-limiting factor is gene expression, not mineral supply.
Similarly, manganese's role in pyruvate carboxylase — an enzyme in gluconeogenesis — is sometimes cited as evidence that manganese 'supports healthy blood sugar.' But this enzyme's activity is hormonally regulated, not mineral-limited, in non-deficient individuals. There is no clinical evidence that supplemental manganese improves insulin sensitivity, lowers blood glucose, or enhances antioxidant capacity in people with adequate dietary intake.
Bottom line
The MnSOD antioxidant argument for supplemental manganese sounds compelling but does not hold up — MnSOD activity is not limited by manganese in non-deficient adults, and there is no clinical evidence that supplemental manganese improves insulin sensitivity or antioxidant capacity in people with adequate dietary intake.
Mineral Competition — How Iron, Calcium, and Magnesium Affect Manganese Absorption
Manganese does not have its own dedicated absorption pathway. It shares the divalent metal transporter-1 (DMT1) in the small intestine with iron, calcium, and magnesium. This means these minerals compete for the same entry point into your bloodstream.
The practical implication is significant for GLP-1 patients, who are often taking multiple mineral supplements. Iron supplementation is common when dietary intake drops due to reduced appetite and meat consumption. Calcium and magnesium are frequently supplemented for bone health and muscle cramping. When taken together with manganese, all of these minerals can reduce each other's absorption.
The competition works both ways: high manganese intake can impair iron absorption, which is particularly concerning for patients already at risk for iron deficiency. The standard mitigation strategy is to separate mineral supplements by at least two hours — taking iron in the morning and any manganese-containing product in the evening, for example.
GLP-1 medications add another layer of complexity. By slowing gastric emptying, they change the kinetics of how minerals move from the stomach into the small intestine where DMT1-mediated absorption occurs. This effect on manganese absorption specifically has not been studied, but it is reasonable to assume that the prolonged transit time could alter the competitive dynamics at the transporter. This remains theoretical but worth acknowledging.
Bottom line
Manganese shares its intestinal absorption transporter with iron, calcium, and magnesium — GLP-1 patients who are taking several mineral supplements simultaneously may have significantly reduced manganese absorption regardless of their supplement dose, and also reduced absorption of those competing minerals; spacing mineral supplements by 2 hours mitigates this.
Practical Assessment — Do GLP-1 Patients Need a Manganese Supplement?
For the vast majority of people taking semaglutide, tirzepatide, or any other GLP-1 medication, the answer is no. Manganese deficiency is extremely rare in adults eating a varied diet, and the risk of toxicity from unnecessary supplementation outweighs any theoretical benefit.
The only scenarios where manganese supplementation should be considered are documented deficiency — which requires laboratory confirmation — or conditions that severely impair absorption, such as inflammatory bowel disease or post-bariatric surgery malabsorption. Even then, supplementation should be managed by a clinician who can monitor manganese status and liver function.
A standard multivitamin that provides 1 to 3 mg of manganese is generally safe for most adults without liver disease. This amount sits above the AI but well below the 11 mg UL. The red flags to watch for are products that provide 5 mg or more of manganese per serving — these deserve scrutiny, especially if you are taking multiple supplements that might also contain manganese.
The food-first approach is straightforward: a handful of hazelnuts, a cup of black tea, a serving of whole wheat bread, or some tofu covers your daily manganese needs without approaching the toxicity threshold. If you have liver disease, disclose all supplements to your prescriber and avoid high-manganese products entirely, since your body's primary route for clearing excess manganese is compromised.
- Who needs supplementation: documented deficiency (rare), severe malabsorption disorders
- Safe multivitamin range: 1–3 mg manganese per serving
- Red flag: any product providing ≥5 mg manganese per serving
- Contraindication: liver disease (impaired biliary manganese excretion)
- Food-first sources: hazelnuts, black tea, whole wheat, tofu, mussels, pineapple
Bottom line
Most GLP-1 patients do not need a separate manganese supplement — dietary intake is sufficient, and the narrow margin between the adequate intake and the upper limit means unsupervised supplementation has a worse benefit-to-risk ratio than almost any other mineral; a standard multivitamin providing 1–3 mg covers the trace mineral role without approaching toxicity.
What most pages leave out
Most supplement content on manganese focuses on its antioxidant and 'blood sugar support' marketing claims without quantifying the UL (11 mg/day — a number that exposes how close standard 'high potency' mineral supplements come to the toxicity threshold); this page is distinguished by the honest assessment that the MnSOD argument does not translate to clinical benefit in non-deficient adults and by explicitly naming manganism as a real risk.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
There is no pharmacokinetic interaction between manganese and semaglutide. The main concern is not the drug combination but manganese's own narrow safety window — the upper limit is only 11 mg per day, and most people already get enough from food. A separate manganese supplement is unnecessary for the vast majority of people.
The same rationale applies as with semaglutide: no direct interaction exists. The safety issue is manganese itself, not the drug pairing. Do not exceed 11 mg of manganese per day from all supplement sources combined, and be aware that many trace mineral complexes contain manganese at doses close to this limit.
No. While manganese is a cofactor for enzymes involved in carbohydrate metabolism, there is no clinical evidence that supplemental manganese lowers blood glucose or improves insulin sensitivity in people who are not manganese-deficient. The MnSOD antioxidant role is real but does not translate to measurable metabolic benefit from supplementation.
The hallmark signs of manganese toxicity (manganism) are tremors, muscle rigidity, gait changes, and psychiatric symptoms such as mood swings, anxiety, or compulsive behaviors. These resemble Parkinson's disease. If any neurological symptoms appear while taking manganese supplements, discontinue immediately and seek medical evaluation.
Black tea, hazelnuts, whole wheat bread, tofu, mussels, and pineapple are all excellent dietary sources. A single cup of black tea can provide over 0.5 mg, and an ounce of hazelnuts delivers roughly 1.6 mg. Most adults meet the adequate intake of 1.8–2.3 mg per day through diet alone.
These are entirely different minerals with different clinical relevance. Magnesium has well-documented benefits for GLP-1 patients, including reducing muscle cramps, supporting insulin sensitivity, and managing constipation. Manganese is a trace mineral with no established GLP-1-specific benefit and a real neurotoxicity risk at high doses.
Yes. Manganese and iron compete for the same absorption transporter (DMT1) in the small intestine. Taking them together can reduce the absorption of both. If you need to take both, separate them by at least two hours — for example, iron in the morning and any manganese-containing supplement in the evening.
Most standard multivitamins provide between 1 and 3 mg of manganese per serving. This is above the adequate intake but well below the 11 mg upper limit, making it generally safe for adults without liver disease. The concern arises with high-potency mineral complexes that may deliver 5 to 10 mg per serving.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
How Coenzyme Q10 (CoQ10) Interacts with Weight Loss Medications
CoQ10 has no direct interaction with semaglutide or tirzepatide, but GLP-1s reduce fat intake and slow gastric emptying, which can lower CoQ10 absorption. Learn timing and form strategies.
Read moreHow Evening Primrose Oil Interacts with Weight-Loss Medications
Evening primrose oil can increase bleeding risk and lower the seizure threshold. Learn how GLP-1 meds affect absorption and why caution is warranted.
Read moreHow L-Glutamine Interacts with Weight-Loss Medications
Does L-glutamine interact with Ozempic, Wegovy, or Zepbound? A detailed, honest look at the evidence, risks, and what we still don't know about combining them.
Read moreHow Bee Pollen Interacts with Weight Loss Medications
Bee pollen has no direct drug interaction with GLP-1s, but its anaphylaxis risk can be masked by common side effects like nausea. Learn the safety steps.
Read moreHow Chamomile Interacts with Weight Loss Medications
Chamomile has no direct interaction with semaglutide or tirzepatide, but its mild sedative and antiplatelet effects require caution. Learn the honest risks and benefits.
Read moreHow Hemp Oil Interacts With Weight-Loss Medications
Hemp seed oil has no direct GLP-1 interaction, but antiplatelet effects and CBD confusion matter. Learn the real risks and what to tell your doctor.
Read moreOn a GLP-1, or thinking about one?
If you take Manganese alongside a GLP-1, it helps to have your medication managed by a clinician who sees the whole picture.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
Important: This page is general information, not medical advice, and it does not account for your health or medications. Supplements can interact with prescription drugs in ways that depend on your dose and situation. Curex offers compounded GLP-1 medications through licensed clinicians — compounded medications are not FDA-approved, and the FDA has not evaluated their safety or efficacy. The supplement discussed here is not a Curex product. Always talk to your pharmacist or prescriber before combining a supplement with any weight-loss medication.
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.